Liquor Impacting Brain Activity (Credit-Freepik)
Many of us believe that we are great drinkers and that alcohol does not affect us as much. People who are able to drink without showing any sign of inebriation are known as social drinkers. In short, they are not addicted to alcohol but will not turn down the opportunity to have a good time! While it may seem like it doesn’t affect you, new studies suggest that it is just an illusion, even if you have high tolerance, alcohol affects your cognitive and motor functions more than you think.
The study reveals the below implications and techniques:
Think of it as the foundation for your brain's performance. When brain conductivity is high, information flows smoothly, and that helps your brain in rapid processing and response. On the other hand, low conductivity can hinder cognitive function, leading to slower thinking, impaired memory, and difficulties with coordination.
A study conducted at the Neuroscience Research Australia (NeuRA) and UNSW Science unveiled a startling connection between alcohol consumption and brain conductivity.
While many people brush off the effects of alcohol as temporary changes in behaviour, the reality is much more complex. Beyond the obvious impacts on coordination and judgment, alcohol significantly alters brain function. Alcohol dramatically slowed down brain activity, especially in areas responsible for decision-making, planning, and physical coordination. This decline was so significant that it resembled the brain changes seen in normal ageing. This means even one drink could temporarily accelerate the ageing process of your brain.
The implications of this research are far-reaching. It provides compelling evidence that alcohol consumption has a direct and measurable impact on brain function. The discovery that alcohol can significantly reduce brain conductivity opens new avenues for understanding the neurocognitive effects of alcohol abuse and dependence. While you may not feel like alcohol is affecting you and you have a high tolerance, it most definitely changes and affects your decision-making abilities and impulse control.
Furthermore, the MRI technique employed in the study could be a valuable tool for assessing the impact of other substances on the brain and for developing interventions to mitigate alcohol-related brain damage.
Credit: iStock
Fever, body ache, sore throat or cough? Taking an antibiotic may seem like a quick fix, but it can do more harm than good. Antibiotics treat bacterial infections, not viral illnesses such as colds and flu.
During World Antimicrobial Resistance (AMR) Awareness Week, experts have warned against self-medication, buying antibiotics over the counter and changing prescribed treatment without medical advice. Such practices fuel antimicrobial resistance (AMR), making infections harder to treat.
Dr Jatin Ahuja, Consultant, Infectious Diseases, Indraprastha Apollo Hospital, Delhi, told HealthandMe that resistance is making common bacterial infections increasingly difficult to treat.
"When bacteria develop resistance to multiple classes of antibiotics, fewer effective treatment options remain. This can delay recovery, increase complications and prolong hospital stays. Pneumonia, urinary tract infections and bloodstream infections become particularly challenging when bacteria do not respond to commonly used drugs," he said.
Fever, pain or a sore throat does not automatically mean you need antibiotics.
"Taking antibiotics for viral infections, particularly coughs, colds and flu, does not help recovery," Dr Ahuja said.
Dr Sumit Jain, Director – Internal Medicine, Paras Health, Panchkula, said antibiotics are ineffective against viral infections.
"People will often think that antibiotics are the answer to a fever, body ache, cold, cough or sore throat. They're not. Antibiotics only work against bacterial infections and are of no use at all against viral infections (i.e. the common cold, flu and most of the seasonal respiratory infections)," he told HealthandMe.
Dr Atul Kakar, Chairperson, Internal Medicine, Sir Ganga Ram Hospital, explained that the common cold, flu, most sore throats and many cases of acute bronchitis are caused by viruses.
Viral fevers are generally self-limiting and may resolve within three to seven days with rest, hydration and symptom relief. Antibiotics do not speed up recovery, he told HealthandMe.
Read More: 98 Years After Penicillin: Are We Running Out Of Effective Antibiotics?
Antibiotic resistance develops when bacteria evolve to survive medicines designed to kill them or stop their growth. Inappropriate antibiotic use accelerates this process.
Dr Ahuja warned that resistance to multiple antibiotics leaves doctors with fewer treatment options, increasing the risk of complications and prolonged hospital stays.
Dr Kakar added that resistant bacteria can spread between people at home, in workplaces and in hospitals, making AMR a wider public health threat.
A recent Indian Council of Medical Research (ICMR) study across 20 tertiary-care hospitals found that 61.1% of confirmed infections caused by four major Gram-negative bacteria were carbapenem-resistant.
Published in The Lancet Regional Health – Southeast Asia, the study analysed nearly 1.6 lakh hospitalised patients between April 2022 and April 2025. Patients with resistant infections faced higher mortality, longer hospital stays and substantially higher treatment costs.
The global picture is equally concerning. According to the World Health Organization (WHO), one in six laboratory-confirmed bacterial infections worldwide is already resistant to antibiotics. If current trends persist, drug-resistant infections could contribute to more than 39 million deaths by 2050.
Antibiotics should be taken only when a doctor diagnoses or strongly suspects a bacterial infection.
Dr Ahuja recommended clinical assessment and culture and sensitivity testing, wherever indicated, to identify the bacteria and determine which medicines are likely to work.
Vaccination, hand hygiene and infection-control measures can also help prevent infections and reduce antibiotic use.
Self-medicating, using leftover antibiotics or taking them without a prescription can accelerate resistance and make future bacterial infections harder to treat.
Dr Jain also warned of side effects, including diarrhoea, allergic reactions and disruption of normal gut flora.
He advised against self-medication and recommended consulting a doctor if symptoms persist or worsen.
Antibiotics are not a quick fix for every fever, cough or body ache. Use them only when medically necessary to help keep these medicines effective.
Credit: iStock
The US has lost its measles elimination status after maintaining it for about 26 years. Doctors now warn that declining vaccination rates could trigger a resurgence of other vaccine-preventable diseases, including mumps, rubella and whooping cough.
Measles is highly contagious but preventable with two doses of the measles, mumps and rubella (MMR) vaccine. However, declining vaccination coverage and anti-vaccine rhetoric from US President Donald Trump and Health Secretary Robert F. Kennedy Jr. have raised concerns about the country's ability to contain outbreaks.
Experts fear measles could be the first of several preventable diseases to return.
"This resurgence is an early warning signal demonstrating that vaccination, surveillance, and public trust have all eroded and other preventable diseases are likely to follow," said Rochelle Walensky, who led the Centers for Disease Control and Prevention (CDC) from 2021 to 2023.
Tom Frieden, who headed the CDC from 2009 to 2017, called measles "like a canary in the coal mine for other vaccine-preventable illnesses", warning that it may not be the last disease to resurface, CIDRAP News reported.
The US outbreak has caused more than 5,000 cases and 11 deaths. Declining vaccination coverage and imported cases linked to international travel have added to the spread.
Falling MMR vaccination coverage could also leave Americans vulnerable to mumps and rubella.
Cases of both infections could rise over the next several years, predicted William Schaffner, an infectious disease physician at Vanderbilt Medical Center and spokesperson for the Infectious Diseases Society of America.
He expects mumps to emerge first, given its higher global prevalence. Earlier this year, San Diego State University reported an outbreak among its football team.
Professor Peter Hotez of Texas Children's Hospital warned that measles was just "the first domino to fall".
"I also expect congenital rubella birth defects to return, as well as pertussis next year," he said.
Experts are particularly concerned about pertussis, or whooping cough, as coverage of the diphtheria, tetanus and pertussis (DTaP) vaccine has also declined.
"Whooping cough has a vivid name, and it deserves it," Schaffner said. The bacterial infection inflames the airways, causing breathing difficulties and intense coughing bouts that can produce a distinctive "whoop" sound.
Schaffner recalled diagnosing a young adult based on the sound of their cough alone during his early years as a physician.
Hotez warned that measles could also become a recurring seasonal threat. "Now that measles has returned, we should expect annual late winter to early spring surges just like we did in the pre-vaccine era, and as we've now seen in 2025-2026," he said.
Read More: What Happens After Measles Infection? The Hidden Risks That Can Last For Years
Schaffner is also watching for a possible rise in tetanus cases because the vaccine protecting against whooping cough is administered alongside tetanus and diphtheria protection.
He also flagged chickenpox, which spreads rapidly among unvaccinated children.
In 2022, an unvaccinated 20-year-old man in Rockland County, New York, contracted polio and developed paralysis.
"It's very distressing, because there is a strong element of turning back the clock, or the calendar, to the bad old days," Schaffner said.
He blamed messaging from Washington that has undermined confidence in vaccines and contributed to growing scepticism.
Hotez suggested considering a three-dose MMR schedule starting at six months, instead of the current recommended starting age of 12 months. He also said some adults born before 1989 may need a second dose.
To regain measles elimination status, the US must interrupt transmission for at least 12 consecutive months before submitting a plan to the World Health Organization (WHO).
Restoring vaccination coverage, strengthening disease surveillance and rebuilding public trust will be essential to preventing further outbreaks.
Credit: TImes Now
Hyderabad-based paediatrician Dr Sivaranjani Santosh has once again demonstrated how a doctor's efforts can extend beyond the clinic. Widely known as the "ORS Lady of India" for her eight-year campaign against sugary beverages falsely marketed as oral rehydration solutions (ORS), she has now helped make a rare disease medicine significantly more affordable.
Through her efforts and collaboration with international organisations, the estimated annual cost of tiratricol treatment for children with Allan-Herndon-Dudley syndrome (AHDS) has fallen from ₹9 crore to approximately ₹2.5 lakh per child.
AHDS, also known as monocarboxylate transporter 8 (MCT8) deficiency, is a rare X-linked genetic disorder that disrupts brain development and movement, primarily affecting males. It is caused by mutations in the SLC16A2 gene, which encodes the protein responsible for transporting thyroid hormones into brain cells.
Seven children with the condition are set to receive a year's supply of tiratricol free of cost on November 30.
"Feeling so relieved! It had been a roller coaster ride!" Dr Sivaranjani shared in a post on X.
The initiative began after Arav, a child under Dr Sivaranjani's care, was diagnosed with AHDS. His mother, Pavitra, was paying approximately ₹12 lakh to ₹13 lakh for a month's supply of the medicine from Germany.
Although tiratricol was available in Europe, its commercial price made it unaffordable for most families. A compounded formulation prepared by Netherlands-based Transvaal Pharmacy is estimated to cost just ₹2.5 lakh per child for a year.
Tiratricol, also known as TRIAC, is a thyroid hormone analogue that helps address hormonal imbalances associated with MCT8 deficiency and reduce complications linked to excess thyroid hormone activity in peripheral tissues.
Transvaal Pharmacy prepared the formulation with support from the Netherlands-based Pharmaceutical Accountability Foundation (PAF).
The medicine has reached India through the appropriate channels and with the necessary permissions. It will be handed over to the seven families, who have secured approvals for one year of treatment.
"Parents of those children I am a paediatrician for donated generously, and Pharmaceutical Accountability Foundation raised funds too. So, the parents of these seven children didn't have to pay a single rupee for the medicine," Dr Sivaranjani said.
As the medicine has a six-month shelf life, it will be imported in two batches, The Hindu reported.
Read More: Rare Diseases Day: How AI Is Transforming Early Diagnosis
According to PAF, providing one year's treatment to all seven children will cost €14,200, approximately ₹15.08 lakh.
Dr Sivaranjani raised approximately ₹6.09 lakh in India, while PAF undertook to raise the remaining €8,600, approximately ₹9.13 lakh, in the Netherlands.
The contributions will ensure that all seven families receive the medicine free of cost.
Attempts to access tiratricol through Egetis Therapeutics' compassionate-use programme failed. On September 7, Dr Sivaranjani appealed for help on social media, bringing the case to the attention of PAF. The foundation then worked with Transvaal Pharmacy to develop a compounded formulation using the active pharmaceutical ingredient for the seven children.
Calling the situation an example of "pharma piracy", Dr Sivaranjani questioned why a medicine that could be compounded for approximately ₹2.5 lakh was being made inaccessible to families through commercial
pricing of around ₹9 crore.
Dr Sivaranjani has urged the Indian government to enable domestic compounding of the active pharmaceutical ingredient (API) and make the medicine available under the National Policy for Rare Diseases. "We can easily prepare it here, and it would cost even less," she said.
© $2026 Times Horizon Private Limited